1. Home
  2. BCDA vs EDBL Comparison

BCDA vs EDBL Comparison

Compare BCDA & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCDA

BioCardia Inc.

HOLD

Current Price

$1.21

Market Cap

14.5M

Sector

Health Care

ML Signal

HOLD

Logo Edible Garden AG Incorporated

EDBL

Edible Garden AG Incorporated

HOLD

Current Price

$0.55

Market Cap

4.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
EDBL
Founded
N/A
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
14.5M
4.0M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
BCDA
EDBL
Price
$1.21
$0.55
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
90.8K
131.8K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,553,000.00
Revenue This Year
N/A
$29.56
Revenue Next Year
N/A
$20.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.56
52 Week High
$3.20
$10.60

Technical Indicators

Market Signals
Indicator
BCDA
EDBL
Relative Strength Index (RSI) 34.21 23.06
Support Level $1.16 $1.13
Resistance Level $1.34 $1.47
Average True Range (ATR) 0.09 0.14
MACD -0.02 -0.06
Stochastic Oscillator 5.33 6.33

Price Performance

Historical Comparison
BCDA
EDBL

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: